Replies to post #29872 on Humanigen Inc (HGENQ)

[Scooter McCabe]

Well here is to only 1000 cases a day. That would be a major victory, but the problem is the current trend for new cases doesn't suggest 1000 cases a day in July.

https://www.google.com/search?q=US+covid+infection+rate&oq=US+covid+infection+rate&aqs=chrome..69i57j0l5j0i457j0l3.4263j0j15&sourceid=chrome&ie=UTF-8

The trendline shows a slow decrease but there is a major problem. The decrease coincides with better weather and outdoor activity. This time last year we saw lower numbers before the spike again in the winter.

So we know the FDA and CDC are unsure if the vaccines will or won't require booster shots. The level of efficacy against the variants and the need to prepare for those new infections.

Also I don't know why you are only focusing on the US. In the event of an EUA other countries will also approve the drug. So sales will be international. It's a big miss to not include that the analysis of the company's prospects.

[DonDonDonDon]

there will be less than a 1,000 new cases per day in the U.S. by July (if not sooner)

You said this on May 29th. Right now we are averaging 14,885 new cases a day. That is a 16% increase from a week ago. We are now averaging 2,037 new hospitalizations a day. That is an 8.6% increase from a week ago.

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html

[DonDonDonDon]

Except hospitalizations are falling significantly (only 27,000 total today) and there will be less than a 1,000 new cases per day in the U.S. by July (if not sooner) and at best a very small portion of those patients May benefit from Lenz. The pool of patients is shrinking everyday...

Hmmmm........